The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.
Academic rigor, journalistic flair
Articles on Moderna bivalent vaccine
Displaying all articles
The next COVID wave has already hit our shores. Make sure you check whether you’re recommended for another booster dose of vaccine.
As the virus that causes COVID evolves, keeping up with it remains a challenge for variant-specific vaccines. The booster you can get now is the best one to get.
The CDC’s endorsement of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.
The UK has become the first country to approve the shot, which targets omicron alongside the original strain of SARS-CoV-2.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Top contributors
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Instructor of Human Immunology, Emory University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
